Loading company…
MediSpan develops immunotherapies for age-related illnesses and anti-aging applications.
Founded in 2020 and based in Seongnam, South Korea, MediSpan develops immunotherapies for age-related illnesses. Its research includes inflammatory growth disorders, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, and infectious diseases. In May 2021, it raised KRW 6.5 billion in Series A funding from DSC Investment, Starset Investment, and Tigris Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in